Mattarollo SR - Search Results

1

Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours.

Nicol AJ, Tokuyama H, Mattarollo SR, Hagi T, Suzuki K, Yokokawa K, Nieda M. Nicol AJ, et al. Among authors: mattarollo sr. Br J Cancer. 2011 Sep 6;105(6):778-86. doi: 10.1038/bjc.2011.293. Epub 2011 Aug 16. Br J Cancer. 2011. PMID: 21847128 Free PMC article. Clinical Trial.

2

Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24+ NKT cell-mediated cytotoxicity.

Mattarollo SR, Kenna T, Nieda M, Nicol AJ. Mattarollo SR, et al. Int J Cancer. 2006 Oct 1;119(7):1630-7. doi: 10.1002/ijc.22019. Int J Cancer. 2006. PMID: 16646079 Free article.

3

Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.

Mattarollo SR, Kenna T, Nieda M, Nicol AJ. Mattarollo SR, et al. Cancer Immunol Immunother. 2007 Aug;56(8):1285-97. doi: 10.1007/s00262-007-0279-2. Epub 2007 Jan 31. Cancer Immunol Immunother. 2007. PMID: 17265022

4

V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs--rituximab and trastuzumab.

Tokuyama H, Hagi T, Mattarollo SR, Morley J, Wang Q, So HF, Moriyasu F, Nieda M, Nicol AJ. Tokuyama H, et al. Among authors: mattarollo sr. Int J Cancer. 2008 Jun 1;122(11):2526-34. doi: 10.1002/ijc.23365. Int J Cancer. 2008. PMID: 18307255 Free article.

5

β-Adrenergic Signaling Impairs Antitumor CD8⁺ T-cell Responses to B-cell Lymphoma Immunotherapy.

Nissen MD, Sloan EK, Mattarollo SR. Nissen MD, et al. Among authors: mattarollo sr. Cancer Immunol Res. 2018 Jan;6(1):98-109. doi: 10.1158/2326-6066.CIR-17-0401. Epub 2017 Nov 16. Cancer Immunol Res. 2018. PMID: 29146881

6

Therapeutic Efficacy of 4-1BB Costimulation Is Abrogated by PD-1 Blockade in a Model of Spontaneous B-cell Lymphoma.

McKee SJ, Doff BL, Soon MS, Mattarollo SR. McKee SJ, et al. Among authors: mattarollo sr. Cancer Immunol Res. 2017 Mar;5(3):191-197. doi: 10.1158/2326-6066.CIR-16-0249. Epub 2017 Jan 23. Cancer Immunol Res. 2017. PMID: 28115358

7

NKT Cell-Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion.

Lam PY, Kobayashi T, Soon M, Zeng B, Dolcetti R, Leggatt G, Thomas R, Mattarollo SR. Lam PY, et al. Among authors: mattarollo sr. Cancer Immunol Res. 2019 Jun;7(6):952-962. doi: 10.1158/2326-6066.CIR-18-0650. Epub 2019 May 3. Cancer Immunol Res. 2019. PMID: 31053598

8

The duality of macrophage function in chronic lymphocytic leukaemia.

Chen YCE, Mapp S, Blumenthal A, Burgess ML, Mazzieri R, Mattarollo SR, Mollee P, Gill D, Saunders NA. Chen YCE, et al. Among authors: mattarollo sr. Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):176-182. doi: 10.1016/j.bbcan.2017.03.006. Epub 2017 Mar 24. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28347751 Review.

9

CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy.

Ma Y, Mattarollo SR, Adjemian S, Yang H, Aymeric L, Hannani D, Portela Catani JP, Duret H, Teng MW, Kepp O, Wang Y, Sistigu A, Schultze JL, Stoll G, Galluzzi L, Zitvogel L, Smyth MJ, Kroemer G. Ma Y, et al. Among authors: mattarollo sr. Cancer Res. 2014 Jan 15;74(2):436-45. doi: 10.1158/0008-5472.CAN-13-1265. Epub 2013 Dec 3. Cancer Res. 2014. PMID: 24302580

10

Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.

Bhat P, Mattarollo SR, Gosmann C, Frazer IH, Leggatt GR. Bhat P, et al. Among authors: mattarollo sr. Immunol Rev. 2011 Jan;239(1):85-98. doi: 10.1111/j.1600-065X.2010.00966.x. Immunol Rev. 2011. PMID: 21198666 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page